Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001Erasca will also present ...

Poster presentations may not seem as prestigious ... They may not be able to see each poster clearly — for example, they may be viewing it from a meter's distance, from a sharp angle of ...

Erasca will also present potential first-in-class examples of direct SMP complex ... today announced the company will present three poster presentations at the upcoming American Association ...

SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies ...